{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:44Z","timestamp":1790912504785,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM044931"],"award-info":[{"award-number":["R01 GM044931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.chroma.2017.03.056","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T03:29:17Z","timestamp":1490239757000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling"],"prefix":"10.1016","volume":"1497","author":[{"given":"Sandya","family":"Beeram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2017.03.056_bib0005","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2174\/138920008786485065","article-title":"Plasma\/serum protein binding determinations","volume":"9","author":"Banker","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.chroma.2017.03.056_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jssc.200800640","article-title":"Characterization of drug-protein interactions in blood using high-performance affinity chromatography","volume":"32","author":"Hage","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2017.03.056_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00216-010-3737-1","article-title":"Drug\u2013protein binding: a critical review of analytical tools","volume":"398","author":"Vuignier","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ddtec.2015.09.003","article-title":"Kinetic analysis of drug\u2013protein interactions by affinity chromatography","volume":"17","author":"Bi","year":"2015","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.chroma.2017.03.056_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpba.2015.01.042","article-title":"Analytical methods for kinetic studies of biological interactions: a review","volume":"113","author":"Zheng","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2017.03.056_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","article-title":"Alpha-1-acid glycoprotein","volume":"1482","author":"Fournier","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chroma.2017.03.056_bib0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DMR-100104402","article-title":"Human alpha-1-glycoprotein and its interactions with drugs","volume":"33","author":"Israili","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.chroma.2017.03.056_bib0040","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1039\/c1ay05068k","article-title":"Chromatographic analysis of drug interactions in the serum proteome","volume":"3","author":"Hage","year":"2011","journal-title":"Anal. Methods"},{"key":"10.1016\/j.chroma.2017.03.056_bib0045","first-page":"21","article-title":"Protein bonding of drugs. Rapid determination by means of continuous ultra filtration","volume":"28","author":"Heinze","year":"2005","journal-title":"Bioforum"},{"key":"10.1016\/j.chroma.2017.03.056_bib0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.2042-7158.1984.tb04891.x","article-title":"On the usefulness of ultrafiltration in drug-protein binding studies","volume":"36","author":"Zhirkov","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.chroma.2017.03.056_bib0055","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.bbagen.2006.03.026","article-title":"Characterization of the interaction between human serum albumin and morin","volume":"1760","author":"Xie","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chroma.2017.03.056_bib0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2133\/dmpk.24.342","article-title":"Lessons from the crystallographic analysis of small molecule binding to human serum albumin","volume":"24","author":"Curry","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.chroma.2017.03.056_bib0065","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/cc800122m","article-title":"Estimating protein-ligand binding affinity using high throughput screening by NMR","volume":"10","author":"Shortridge","year":"2008","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0070","series-title":"Handbook of Affinity Chromatography","first-page":"699","article-title":"Affinity ligands in capillary electrophoresis","author":"Heegaard","year":"2006"},{"key":"10.1016\/j.chroma.2017.03.056_bib0075","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/elps.200700748","article-title":"Study of interaction between drug enantiomers and human serum albumin by flow injection-capillary electrophoresis frontal analysis","volume":"29","author":"Liu","year":"2008","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2017.03.056_bib0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jps.10293","article-title":"Characterizing a drug\u2019s primary binding site on albumin","volume":"92","author":"Day","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2017.03.056_bib0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jssc.200500501","article-title":"Applications of silica supports in affinity chromatography","volume":"29","author":"Schiel","year":"2006","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2017.03.056_bib0090","series-title":"Analytical Affinity Chromatography","author":"Chaiken","year":"1987"},{"key":"10.1016\/j.chroma.2017.03.056_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpba.2012.01.004","article-title":"Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments","volume":"69","author":"Hage","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2017.03.056_bib0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.chroma.2003.11.092","article-title":"Determination of binding constants by affinity chromatography","volume":"1037","author":"Winzor","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.056_bib0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/138920011795202938","article-title":"Characterization of drug interactions with serum proteins by using high-performance affinity chromatography","volume":"12","author":"Hage","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.chroma.2017.03.056_bib0110","series-title":"Handbook of Affinity Chromatography","first-page":"595","article-title":"Quantitative affinity chromatography: practical aspects","author":"Hage","year":"2006"},{"key":"10.1016\/j.chroma.2017.03.056_bib0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/ac010643c","article-title":"Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: exemplification of the method using L-tryptophan and albumin","volume":"74","author":"Talbert","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0120","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1021\/ac9000404","article-title":"Measurement of drug-protein dissociation rates by high performance affinity chromatography and peak profiling","volume":"81","author":"Schiel","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0125","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/jssc.201100280","article-title":"High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths","volume":"34","author":"Yoo","year":"2011","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2017.03.056_bib0130","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.chroma.2010.10.070","article-title":"Kinetic studies of drug\u2013protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns","volume":"1218","author":"Tong","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.056_bib0135","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.chroma.2010.02.026","article-title":"Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin","volume":"1217","author":"Mallik","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.056_bib0140","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1021\/ac201973v","article-title":"Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: analysis of free drug fractions","volume":"83","author":"Schiel","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0145","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1039\/c3an01315d","article-title":"Analysis of free fractions for chiral drugs using ultrafast extraction and multi-dimensional high-performance affinity chromatography","volume":"138","author":"Zheng","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.chroma.2017.03.056_bib0150","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/ac501031y","article-title":"Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"86","author":"Zheng","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0155","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1021\/acs.analchem.5b03007","article-title":"Analysis of hormone-protein binding in solution by ultrafast affinity extraction: interactions of testosterone with human serum albumin and sex hormone binding globulin","volume":"87","author":"Zheng","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ab.2008.01.035","article-title":"Immobilization of \u03b11-acid glycoprotein for chromatographic studies of drug\u2013protein binding. II. Correction for errors in association constant measurements","volume":"376","author":"Mallik","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2014.01.026","article-title":"Analysis of biomolecular interactions using affinity microcolumns: a review","volume":"968","author":"Zheng","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2017.03.056_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9673(94)80332-3","article-title":"Development of dihydrazide-activated silica supports for high-performance affinity chromatography","volume":"669","author":"Ruhn","year":"1994","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.056_bib0175","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ab.2005.08.025","article-title":"Immobilization of \u03b11-acid glycoprotein for chromatographic studies of drug-protein binding","volume":"346","author":"Xuan","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jchromb.2015.11.021","article-title":"Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies","volume":"1021","author":"Bi","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2017.03.056_bib0185","series-title":"Clinical and Pharmaceutical Applications of High-performance Affinity Chromatography","author":"Schiel","year":"2009"},{"key":"10.1016\/j.chroma.2017.03.056_bib0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ab.2010.05.004","article-title":"Entrapment of proteins in glycogen-capped and hydrazide-activated supports","volume":"404","author":"Jackson","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/clpt.1983.66","article-title":"Verapamil plasma binding: relationship to \u03b11-acid glycoprotein and drug efficacy","volume":"33","author":"McGowan","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.chroma.2017.03.056_bib0200","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jchromb.2010.01.016","article-title":"Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography","volume":"878","author":"Soman","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2017.03.056_bib0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00502459","article-title":"Determination of free fractions of tricyclic antidepressants","volume":"327","author":"Nyberg","year":"1984","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.chroma.2017.03.056_bib0210","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/clpt.1984.93","article-title":"Imipramine binding to alpha-1-acid glycoprotein in normal subjects and cardiac patients","volume":"35","author":"Freilich","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.chroma.2017.03.056_bib0215","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0024-3205(84)90408-9","article-title":"Stereoselective binding of disopyramide to human plasma protein","volume":"35","author":"Lima","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.chroma.2017.03.056_bib0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0003-2697(88)90488-5","article-title":"Sequestration electrochemistry: the interaction of chlorpromazine and human orosomucoid","volume":"171","author":"Wright","year":"1988","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2017.03.056_bib0225","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM197812282992604","article-title":"Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma \u03b11 acid glycoprotein","volume":"299","author":"Piafsky","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2017.03.056_bib0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1009935116877","article-title":"Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs","volume":"15","author":"Regenthal","year":"1999","journal-title":"J. Clin. Monit."},{"key":"10.1016\/j.chroma.2017.03.056_bib0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpba.2008.04.030","article-title":"Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots","volume":"48","author":"Barri","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2017.03.056_bib0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2014.10.092","article-title":"Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin","volume":"1371","author":"Zheng","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2017.03.056_bib0245","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<751::AID-JPS6>3.0.CO;2-8","article-title":"Enantioselective binding of propranolol, disopyramide, and verapamil to human \u03b11-acid glycoprotein","volume":"89","author":"Handa","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2017.03.056_bib0250","series-title":"Chemical Kinetics and Reaction Mechanisms","author":"Espenson","year":"2002"},{"key":"10.1016\/j.chroma.2017.03.056_bib0255","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.chroma.2010.09.070","article-title":"Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug\u2013protein dissociation rates","volume":"1218","author":"Yoo","year":"2011","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002196731730451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002196731730451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T05:44:29Z","timestamp":1758260669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002196731730451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":51,"alternative-id":["S002196731730451X"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2017.03.056","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2017.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}